157 related articles for article (PubMed ID: 32554846)
1. Serum betatrophin and irisin levels in hepatocellular carcinoma.
Pazgan-Simon M; Zuwala-Jagiello J; Menzyk T; Bator M; Derra A; Lekstan A; Grzebyk E; Simon K; Kukla M
J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554846
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
3. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
[TBL] [Abstract][Full Text] [Related]
4. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients.
Wang L; Song J; Wang C; Lin P; Liang K; Sun Y; He T; Li W; Zhao R; Qin J; Lu Y; Liu J; Liu F; Hou X; Chen L
J Diabetes Res; 2016; 2016():2616539. PubMed ID: 26649318
[TBL] [Abstract][Full Text] [Related]
5. Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.
Zhang J; Ke M; Ren Y; Bi J; Du Z; Zhang M; Wang Y; Zhang L; Wu Z; Lv Y; Wu R
Dis Markers; 2019; 2019():9850191. PubMed ID: 31976024
[TBL] [Abstract][Full Text] [Related]
6. Plasma betatrophin levels in patients with liver cirrhosis.
Arias-Loste MT; García-Unzueta MT; Llerena S; Iruzubieta P; Puente A; Cabezas J; Alonso C; Cuadrado A; Amado JA; Crespo J; Fábrega E
World J Gastroenterol; 2015 Oct; 21(37):10662-8. PubMed ID: 26457026
[TBL] [Abstract][Full Text] [Related]
7. Increased Maternal and Cord Blood Betatrophin in Gestational Diabetes.
Wawrusiewicz-Kurylonek N; Telejko B; Kuzmicki M; Sobota A; Lipinska D; Pliszka J; Raczkowska B; Kuc P; Urban R; Szamatowicz J; Kretowski A; Laudanski P; Gorska M
PLoS One; 2015; 10(6):e0131171. PubMed ID: 26115519
[TBL] [Abstract][Full Text] [Related]
8. Several Circulating Biomarkers for PCOS Diagnosis.
Luo P; Zhang C; He Y; Yang G; Liu H; Li L
Exp Clin Endocrinol Diabetes; 2021 Oct; 129(10):705-712. PubMed ID: 31683329
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.
Franck M; Schütte K; Malfertheiner P; Link A
World J Gastroenterol; 2020 Jan; 26(1):86-96. PubMed ID: 31933516
[TBL] [Abstract][Full Text] [Related]
10. Serum betatrophin/angiopoietin-like protein 8 (ANGPTL8) levels in pregnancies affected by hyperemesis gravidarum.
Timur B; Tuncer SF; Bodur S; Timur H; Tokmak A; Gucel F; Altay M
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():221-227. PubMed ID: 29754072
[TBL] [Abstract][Full Text] [Related]
11. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
[TBL] [Abstract][Full Text] [Related]
12. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes.
Susanto H; Liu TY; Chen CC; Purnomo JD; Chen SF; Wang CH
Oncotarget; 2016 Jul; 7(27):42330-42339. PubMed ID: 27276680
[TBL] [Abstract][Full Text] [Related]
13. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
14. Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls.
Ebert T; Kralisch S; Wurst U; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Tönjes A; Fasshauer M
Eur J Endocrinol; 2015 Jul; 173(1):1-7. PubMed ID: 25850828
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
17. Circulating betatrophin in healthy control and type 2 diabetic subjects and its association with metabolic parameters.
Al-Daghri NM; Rahman S; Sabico S; Amer OE; Wani K; Ansari MG; Al-Attas OS; Kumar S; Alokail MS
J Diabetes Complications; 2016; 30(7):1321-5. PubMed ID: 27311786
[TBL] [Abstract][Full Text] [Related]
18. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
19. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
